SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-23-000079
Filing Date
2023-05-17
Accepted
2023-05-17 07:31:45
Documents
14
Period of Report
2023-05-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20230517.htm   iXBRL 8-K 41487
2 EX-99.1 a2seventybiopr51723final.htm EX-99.1 33058
6 image_0.jpg GRAPHIC 31087
  Complete submission text file 0001860782-23-000079.txt   268781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20230517.xsd EX-101.SCH 2008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20230517_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20230517_pre.xml EX-101.PRE 13142
8 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20230517_htm.xml XML 11656
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 23929640
SIC: 2834 Pharmaceutical Preparations